Physician profile
Collin C Vu
NPI 1225244775
$16,903.78
in general payments reported to CMS, 2019-2025
83 companies · $3,468 in 2025
The $3,468 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $867 · 2020: $470 · 2021: $2,587 · 2022: $3,214 · 2023: $3,109 · 2024: $3,189 · 2025: $3,468.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,545 · Education: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,544.56 |
| Education | $222.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,344.97 | 2019-2025 | |
| Janssen Biotech, INC. | $964.46 | 2019-2025 | Darzalex, Talvey, Tecvayli |
| Merck Sharp & Dohme LLC | $932.67 | 2020-2025 | Keytruda, Welireg, Lynparza |
| E.R. Squibb & Sons, L.L.C. | $802.60 | 2019-2025 | Opdivo, Opdualag, Eliquis |
| Pfizer INC. | $747.45 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $719.12 | 2020-2023 | Imbruvica, Epkinly |
| Astrazeneca Pharmaceuticals LP | $684.16 | 2020-2025 | Calquence, Imfinzi, Tagrisso |
| Regeneron Healthcare Solutions, INC. | $559.65 | 2022-2025 | Libtayo |
| Incyte Corporation | $555.83 | 2021-2025 | Jakafi, Monjuvi, Zynyz |
| Eisai INC. | $539.55 | 2019-2025 | |
| Gilead Sciences, INC. | $532.13 | 2019-2025 | Trodelvy |
| Genentech USA, INC. | $492.00 | 2019-2025 | Polivy, Tecentriq, Itovebi |
| Takeda Pharmaceuticals U.S.A., INC. | $417.89 | 2021-2025 | Fruzaqla, Alunbrig, Iclusig |
| Daiichi Sankyo INC. | $405.20 | 2020-2025 | Enhertu, Datroway |
| Abbvie INC. | $403.60 | 2019-2025 |
Show all 83 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $400.69 | 2019-2025 | Lumakras, Nplate, Xgeva |
| Bayer Healthcare Pharmaceuticals INC. | $361.81 | 2019-2025 | |
| Celgene Corporation | $360.07 | 2020-2025 | Reblozyl, Pomalyst |
| Glaxosmithkline, LLC. | $340.60 | 2020-2025 | Jemperli, Ojjaara, Zejula |
| Boehringer Ingelheim Pharmaceuticals, INC. | $309.06 | 2019-2025 | Gilotrif |
| Astellas Pharma US INC | $272.70 | 2019-2025 | Vyloy, Padcev, Xtandi |
| Exelixis INC. | $200.65 | 2021-2025 | Cabometyx |
| Genzyme Corporation | $200.12 | 2021-2024 | |
| Array Biopharma INC | $197.14 | 2020-2025 | Braftovi, Mektovi, Tukysa |
| Seagen INC. | $193.41 | 2021-2023 | Padcev |
| Puma Biotechnology, INC. | $166.01 | 2023-2025 | |
| Beigene USA, INC. | $154.30 | 2021-2024 | Brukinsa |
| Blueprint Medicines Corporation | $152.92 | 2022-2024 | Ayvakit |
| Taiho Oncology, INC. | $148.72 | 2022-2025 | |
| Pharmaessentia USA Corporation | $148.30 | 2023-2025 | Besremi |
| Karyopharm Therapeutics INC. | $143.03 | 2021-2025 | Xpovio |
| Lilly USA, LLC | $129.97 | 2021-2024 | Jaypirca, Retevmo, Verzenio |
| Myovant Sciences INC. | $123.46 | 2021-2022 | |
| Foundation Medicine, INC. | $120.46 | 2019-2020 | |
| Cardinal Health 110 LLC | $112.70 | 2024 | |
| Emd Serono, INC. | $112.53 | 2022-2024 | Bavencio |
| Rigel Pharmaceuticals, INC. | $108.61 | 2022-2025 | Rezlidhia, Tavalisse, Gavreto |
| Aveo Pharmaceuticals, INC. | $106.69 | 2021-2025 | Fotivda |
| Tempus Ai, INC | $106.57 | 2024 | |
| Stemline Therapeutics INC. | $106.28 | 2023-2025 | Orserdu, Elzonris |
| Alexion Pharmaceuticals, INC. | $101.38 | 2019-2025 | Ultomiris |
| Organon LLC | $99.99 | 2021-2023 | Ontruzant |
| Mylan Institutional INC. | $99.53 | 2019-2022 | |
| Adc Therapeutics America, INC. | $84.66 | 2022-2025 | |
| Mirati Therapeutics, INC. | $81.29 | 2023-2024 | Krazati |
| Deciphera Pharmaceuticals INC. | $81.13 | 2023-2024 | Qinlock |
| Springworks Therapeutics, INC. | $74.99 | 2024-2025 | Ogsiveo |
| Dova Pharmaceuticals | $74.74 | 2020-2021 | |
| Immunogen, INC. | $73.17 | 2023 | Elahere |
| Sumitomo Pharma America, INC. | $72.04 | 2023-2024 | Orgovyx |
| Ipsen Biopharmaceuticals, INC | $70.40 | 2019-2025 | Onivyde, Somatuline Depot |
| Coherus Oncology, INC. | $64.18 | 2020-2025 | Loqtorzi |
| Kite Pharma, INC. | $63.87 | 2021-2022 | |
| Adaptive Biotechnologies Corporation | $59.20 | 2025 | Clonoseq |
| Sobi, INC | $53.99 | 2022-2024 | |
| Beone Medicines USA, INC. | $50.97 | 2025 | Brukinsa |
| Jazz Pharmaceuticals INC. | $50.57 | 2022-2023 | |
| Dendreon Pharmaceuticals LLC | $45.45 | 2019 | |
| Acrotech Biopharma INC. | $44.86 | 2022-2023 | Beleodaq |
| Tersera Therapeutics LLC | $44.40 | 2020-2021 | |
| Accord Healthcare, INC. | $44.11 | 2025 | |
| Heron Therapeutics, INC. | $39.76 | 2020-2021 | |
| Immunocore Limited | $39.01 | 2024 | Kimmtrak |
| Tolmar Pharmaceuticals, INC. | $35.97 | 2019 | |
| Recordati_rare_diseases_inc. | $35.56 | 2025 | Sylvant |
| Ge Healthcare | $35.31 | 2022 | |
| Caris Mpi, INC. | $32.43 | 2025 | Mi Cancer Seek |
| Medtronic, INC. | $31.53 | 2024 | Signia |
| Syndax Pharmaceuticals, INC. | $30.11 | 2025 | |
| Myriad Genetic Laboratories, INC. | $28.90 | 2022 | |
| Janssen Pharmaceuticals, INC | $28.75 | 2020-2021 | |
| Spectrum Pharmaceuticals INC. | $28.52 | 2024 | Rolvedon |
| Telix Pharmaceuticals | $28.43 | 2024 | Illuccix |
| Csl Behring | $24.47 | 2023 | Afstyla, Idelvion |
| Iovance Biotherapeutics, INC. | $24.44 | 2025 | Amtagvi |
| Fennec Pharmaceuticals, INC. | $24.08 | 2025 | Fyarro |
| Servier Pharmaceuticals LLC | $21.73 | 2022 | |
| Apellis Pharmaceuticals, INC. | $20.88 | 2025 | Empaveli |
| Octapharma USA, INC. | $20.49 | 2019 | |
| Kyowa Kirin, INC. | $17.84 | 2023 | Poteligeo |
| Shionogi INC | $16.80 | 2019 | |
| Pharmacosmos Therapeutics INC. | $14.30 | 2022 | |
| Helsinn Therapeutics (U.S.), INC. | $11.47 | 2019 |
Drugs and devices associated with these payments
Keytruda $676Imbruvica $504Libtayo $381Enhertu $264Darzalex $260Lenvima $257Kisqali $248Padcev $238Opdivo $235Fabhalta $234Reblozyl $224Xtandi $203Calquence $194Orgovyx $193Welireg $188Polivy $184Imfinzi $176Elahere $175Braftovi $162Nubeqa $159Talvey $157Epkinly $155Besremi $148Brukinsa $143Talzenna $143Mektovi $137Xofigo $128Tecvayli $128Cabometyx $128Tecentriq $125Jemperli $119Lynparza $117Opdualag $117Xpovio $111Inlyta $110Vyloy $107Tukysa $104Inqovi $101Lonsurf $101Trodelvy $100Scemblix $99.75Elrexfio $95.73Erleada $94.10Rezlidhia $93.36Tavalisse $93.36Fruzaqla $87.21Piqray $85.29Orserdu $84.46Pluvicto $84.42Jakafi $81.96Krazati $81.29Qinlock $81.13Gilotrif $80.11Ayvakit $79.94Ojjaara $78.70Promacta $72.02Adcetris $70.87Rybrevant $70.05Ultomiris $63.02Itovebi $59.21Clonoseq $59.20Zejula $58.61Illuccix $56.86Lumakras $56.75Fotivda $54.90Alunbrig $54.61Jaypirca $53.95Retevmo $53.95Pomalyst $53.74Monjuvi $52.74Nerlynx $52.05Mekinist $51.36Ogsiveo $51.15Ibrance $50.47Eliquis $49.69Bosulif $48.73Zynlonta $48.19Somatuline Depot $48.14Onivyde $48.14Tagrisso $47.67Sarclisa $46.24Loqtorzi $44.53Camcevi $44.11Bavencio $41.34Jevtana $39.88Kimmtrak $39.01Sylvant $35.56Mi Cancer Seek $32.43Ontruzant $31.94Signia $31.53Xgeva $30.34Nplate $30.34Kyprolis $30.03Datroway $29.76Keytruda Qlex $29.04Rolvedon $28.52Zynyz $27.15Lunsumio $27.07Columvi $27.07Stivarga $26.53
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Collin Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.